BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 908031)

  • 1. Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells.
    Krahenbuhl JL; Remington JS
    Cancer Res; 1977 Nov; 37(11):3912-6. PubMed ID: 908031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of activated macrophages on tumor target cells in discrete phases of the cell cycle.
    Krahenbuhl JL
    Cancer Res; 1980 Dec; 40(12):4622-7. PubMed ID: 7438096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential mechanism of macrophage-mediated tumor cell cytotoxicity.
    Kaplan AM; Collins JM; Morahan PS; Snodgrass MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1823-9. PubMed ID: 728900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.
    Ophir R; Ben-Efraim S; Bonta IL
    Int J Tissue React; 1987; 9(3):189-94. PubMed ID: 3596960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nonspecific in vitro cytotoxicity of activated human macrophages on human tumor cells (author's transl)].
    Nagai S
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):2027-36. PubMed ID: 7211218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.
    Krahenbuhl JL; Remington JS
    J Immunol; 1974 Aug; 113(2):507-16. PubMed ID: 4210882
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of macrophage function during Trichinella spiralis infection in mice.
    Wing EJ; Krahenbuhl JL; Remington JS
    Immunology; 1979 Mar; 36(3):479-85. PubMed ID: 437839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
    Droller MJ; Remington JS
    Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-GuĂ©rin-activated host cells simultaneously assayed in vivo and in vitro.
    Normann SJ; Cornelius J
    Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of macrophage-mediated tumor cell cytotoxicity.
    Kaplan AM; Brown J; Collins JM; Morahan PS; Snodgrass MJ
    J Immunol; 1978 Nov; 121(5):1781-9. PubMed ID: 712065
    [No Abstract]   [Full Text] [Related]  

  • 14. Foreign-body tumorigenesis in mice: DNA synthesis in surface-attached cells during preneoplasia.
    Thomassen MJ; Buoen LC; Brand I; Brand KG
    J Natl Cancer Inst; 1978 Aug; 61(2):359-63. PubMed ID: 277723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurements of macrophage-induced cytostasis and cytotoxicity of EMT6 cells by flow cytometry.
    Stevenson AP; Martin JC; Stewart CC
    Cancer Res; 1986 Jan; 46(1):99-105. PubMed ID: 3940215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
    Evans R; Eidlen DM
    J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M; Haskill S
    J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-induced enhancement of endogenous tumor lysosome activity.
    Urban JL
    Cancer Res; 1981 Jun; 41(6):2221-9. PubMed ID: 7237422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.